Articles

Geopolitics threatened to deal a fresh blow to investor confidence on Monday just as stocks appeared to be shaking off the most chaotic stretch of the year.

The U.S. budget deficit in July increased 10% from a year ago, driven by higher government spending and bigger interest payments on the national debt.

Billionaire entrepreneur Elon Musk has promised “no limits on subject matter” as he speaks with Donald Trump tonight at around 8 p.m. Eastern time.

One analyst believes Harris-Walz is “the most progressive ticket” in generations.

10 banks with low commercial real-estate exposure relative to their total equity

Some increase in the wage base is almost inevitable because growing wage inequality has caused the share of wages subject to taxation to decline sharply.

Shares of companies developing treatments based on psilocybin and other psychedelic drugs moved lower on Monday after the U.S. Food and Drug Administration rejected use of MDMA for post-traumatic stress disorder.

LL Flooring, formerly known as Lumber Liquidators, has filed for bankruptcy, which it plans to use to pursue a “going concern” sale of its business.

Melius Research is still upbeat about Dell’s earnings potential, though analyst acknowledges the company needs to soothe investors’ margin fears.

Nvidia’s stock is one of the S&P 500’s best performers in Monday action as BofA outlines why a ‘rebound’ scenario makes sense for the semiconductor sector.

Most of B. Riley’s losses are related to the performance of its investment in Franchise Group Inc. — whose retail brands include Vitamin Shoppe, Pet Supplies Plus and furniture seller American Freight — and its Vintage Capital loan receivable.

The stock of Ascendis Pharma A/S jumped 11% early Monday, after the biotech said the U.S. Food and Drug Administration has approved its Yorvipath as the first and only treatment for a rare endocrine disease.